Unknown

Dataset Information

0

Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach.


ABSTRACT: Emerging studies have demonstrated the potential of PI3Kδ blockade as an immunotherapy for solid tumours. In pre-clinical models, we recently demonstrated that anti-LAG3 immune checkpoint blockade vastly potentiated PI3Kδ-based immunotherapy, enabling successful tumour control in all treated mice.

SUBMITTER: Lauder SN 

PROVIDER: S-EPMC8368216 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7583804 | biostudies-literature
| S-EPMC9176802 | biostudies-literature
| S-EPMC8727303 | biostudies-literature
| S-EPMC1958998 | biostudies-other
| S-EPMC6798348 | biostudies-literature
| S-EPMC9696730 | biostudies-literature
| S-EPMC6721578 | biostudies-literature
| S-EPMC6617297 | biostudies-literature
| S-EPMC5765225 | biostudies-literature
| S-EPMC9274802 | biostudies-literature